Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | NERV | MINERVA NEUROSCIENCES INC | Healthcare | 1,419,000.0 | $8.5M | 1.96% | NEW | — | $6.03 | -18.7% |
| 22 | — | PROMIS NEUROSCIENCES INC | — | 557,103.0 | $7.1M | 1.62% | NEW | — | $12.70 | — |
| 23 | SLGL | SOL-GEL TECHNOLOGIES LTD | Healthcare | 85,496.0 | $6.8M | 1.55% | NEW | — | $79.22 | -18.9% |
| 24 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 2,449,993.0 | $5.5M | 1.27% | NEW | — | $2.26 | -1.5% |
| 25 | — | VTV THERAPEUTICS INC | — | 139,578.0 | $5.5M | 1.27% | -91K | -39.6% | $39.66 | — |
| 26 | SNSE | SENSEI BIOTHERAPEUTICS INC | Healthcare | 125,000.0 | $3.9M | 0.90% | NEW | — | $31.52 | -43.6% |
| 27 | — | OPUS GENETICS INC | — | 500,000.0 | $2.3M | 0.52% | NEW | — | $4.55 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%